pmc logo image
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Pratyaksha Wirapati, Christos Sotiriou, Susanne Kunkel, Pierre Farmer, Sylvain Pradervand, Benjamin Haibe-Kains, Christine Desmedt, Michail Ignatiadis, Thierry Sengstag, Frédéric Schütz, Darlene R Goldstein, Martine Piccart, Mauro Delorenzi
Breast Cancer Res. 2008; 10(4): R65. Published online 2008 July 28. doi: 10.1186/bcr2124
PMCID:
PMC2575538
Abstract Full Text PDF–755K Supplementary Material
Page of 3 Next Last
 Is Cited by the Following 64 Articles in this Archive:
A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer
Robin M. Hallett, Anna Dvorkin-Gheva, Anita Bane, John A. Hassell
Sci Rep. 2012; 2: 227. Published online 2012 January 17. doi: 10.1038/srep00227
PMCID:
PMC3259129
Full Text PDF–752K Supplementary Material
The Influence of Feature Selection Methods on Accuracy, Stability and Interpretability of Molecular Signatures
Anne-Claire Haury, Pierre Gestraud, Jean-Philippe Vert
PLoS One. 2011; 6(12): e28210. Published online 2011 December 21. doi: 10.1371/journal.pone.0028210
PMCID:
PMC3244389
Abstract Full Text PDF–1023K
MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis
Dongwan D. Kang, Etienne Sibille, Naftali Kaminski, George C. Tseng
Nucleic Acids Res. 2012 January; 40(2): e15. Published online 2011 November 23. doi: 10.1093/nar/gkr1071
PMCID:
PMC3258120
Abstract Full Text PDF–3.7M Supplementary Material
Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer
Maurizio Belfiglio, Caterina Fanizza, Nicola Tinari, Corrado Ficorella, Stefano Iacobelli, Clara Natoli, Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO)
J Cancer Res Clin Oncol. 2012 February; 138(2): 221–229. Published online 2011 November 18. doi: 10.1007/s00432-011-1091-0
PMCID:
PMC3258394
Abstract Full Text PDF–627K
Drug Repositioning using Disease Associated Biological Processes and Network Analysis of Drug Targets
Sachin Mathur, Deendayal Dinakarpandian
AMIA Annu Symp Proc. 2011; 2011: 305–311. Published online 2011 October 22.
PMCID:
PMC3243256
Abstract Full Text PDF–154K
Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
David Venet, Jacques E. Dumont, Vincent Detours
PLoS Comput Biol. 2011 October; 7(10): e1002240. Published online 2011 October 20. doi: 10.1371/journal.pcbi.1002240
PMCID:
PMC3197658
Abstract Full Text PDF–443K Supplementary Material
A clinically relevant gene signature in triple negative and basal-like breast cancer
Achim Rody, Thomas Karn, Cornelia Liedtke, Lajos Pusztai, Eugen Ruckhaeberle, Lars Hanker, Regine Gaetje, Christine Solbach, Andre Ahr, Dirk Metzler, Marcus Schmidt, Volkmar Müller, Uwe Holtrich, Manfred Kaufmann
Breast Cancer Res. 2011; 13(5): R97. Published online 2011 October 6. doi: 10.1186/bcr3035
PMCID:
PMC3262210
Abstract Full Text PDF–3.6M Supplementary Material
A clinically relevant gene signature in triple negative and basal-like breast cancer
Achim Rody, Thomas Karn, Cornelia Liedtke, Lajos Pusztai, Eugen Ruckhaeberle, Lars Hanker, Regine Gaetje, Christine Solbach, Andre Ahr, Dirk Metzler, Marcus Schmidt, Volkmar Müller, Uwe Holtrich, Manfred Kaufmann
Breast Cancer Res. 2011; 13(5): R97. Published online 2011 October 6. doi: 10.1186/bcr3035
PMCID:
PMC3262210
Abstract Full Text PDF–3.6M Supplementary Material
Insight into the heterogeneity of breast cancer through next-generation sequencing
Hege G. Russnes, Nicholas Navin, James Hicks, Anne-Lise Borresen-Dale
J Clin Invest. 2011 October 3; 121(10): 3810–3818. Published online 2011 October 3. doi: 10.1172/JCI57088
PMCID:
PMC3195464
Abstract Full Text PDF–1.6M
Breast cancer — one term, many entities?
Nicholas R. Bertos, Morag Park
J Clin Invest. 2011 October 3; 121(10): 3789–3796. Published online 2011 October 3. doi: 10.1172/JCI57100
PMCID:
PMC3195465
Abstract Full Text PDF–1.8M
Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response
Qiyuan Li, Aron C Eklund, Nicolai J Birkbak, Christine Desmedt, Benjamin Haibe-Kains, Christos Sotiriou, W Fraser Symmans, Lajos Pusztai, Søren Brunak, Andrea L Richardson, Zoltan Szallasi
BMC Bioinformatics. 2011; 12: 310. Published online 2011 July 28. doi: 10.1186/1471-2105-12-310
PMCID:
PMC3155975
Abstract Full Text PDF–498K Supplementary Material
Microarray-Based Oncogenic Pathway Profiling in Advanced Serous Papillary Ovarian Carcinoma
Xuan Bich Trinh, Wiebren A. A. Tjalma, Luc Y. Dirix, Peter B. Vermeulen, Dieter J. Peeters, Dimcho Bachvarov, Marie Plante, Els M. Berns, Jozien Helleman, Steven J. Van Laere, Peter A. van Dam
PLoS One. 2011; 6(7): e22469. Published online 2011 July 25. doi: 10.1371/journal.pone.0022469
PMCID:
PMC3143137
Abstract Full Text PDF–551K
A simple method for assigning genomic grade to individual breast tumours
Kristian Wennmalm, Jonas Bergh
BMC Cancer. 2011; 11: 306. Published online 2011 July 21. doi: 10.1186/1471-2407-11-306
PMCID:
PMC3150343
Abstract Full Text PDF–182K Supplementary Material
Induction of Stable Drug Resistance in Human Breast Cancer Cells Using a Combinatorial Zinc Finger Transcription Factor Library
Jeongeun Lee, Andrew S. Hirsh, Ben S. Wittner, Morgan L. Maeder, Rajasekhar Singavarapu, Magdalena Lang, Sailajah Janarthanan, Ultan McDermott, Vijay Yajnik, Sridhar Ramaswamy, J. Keith Joung, Dennis C. Sgroi
PLoS One. 2011; 6(7): e21112. Published online 2011 July 19. doi: 10.1371/journal.pone.0021112
PMCID:
PMC3139592
Abstract Full Text PDF–611K Supplementary Material
A pharmacogenomic method for individualized prediction of drug sensitivity
Adam L Cohen, Raffaella Soldi, Haiyu Zhang, Adam M Gustafson, Ryan Wilcox, Bryan E Welm, Jeffrey T Chang, Evan Johnson, Avrum Spira, Stefanie S Jeffrey, Andrea H Bild
Mol Syst Biol. 2011; 7: 513. Published online 2011 July 19. doi: 10.1038/msb.2011.47
PMCID:
PMC3159972
Abstract Full Text PDF–3.2M Supplementary Material
Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
Françoise Rothé, Michail Ignatiadis, Carole Chaboteaux, Benjamin Haibe-Kains, Naïma Kheddoumi, Samira Majjaj, Bassam Badran, Hussein Fayyad-Kazan, Christine Desmedt, Adrian L. Harris, Martine Piccart, Christos Sotiriou
PLoS One. 2011; 6(6): e20980. Published online 2011 June 29. doi: 10.1371/journal.pone.0020980
PMCID:
PMC3126805
Abstract Full Text PDF–1.0M Supplementary Material
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch, W. C. Wood, A. S. Coates, R. D. Gelber, B. Thürlimann, H.-J. Senn, Panel members
Ann Oncol. 2011 August; 22(8): 1736–1747. Published online 2011 June 27. doi: 10.1093/annonc/mdr304
PMCID:
PMC3144634
Abstract Full Text PDF–122K
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction
Pierre-Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt, Jorge S Reis-Filho
Breast Cancer Res. 2011; 13(3): 212. Published online 2011 June 27. doi: 10.1186/bcr2890
PMCID:
PMC3218943
Abstract Full Text PDF–359K
The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
Fabien Reyal, Roman Rouzier, Berenice Depont-Hazelzet, Marc A. Bollet, Jean-Yves Pierga, Severine Alran, Remy J. Salmon, Virginie Fourchotte, Anne Vincent-Salomon, Xavier Sastre-Garau, Martine Antoine, Serge Uzan, Brigitte Sigal-Zafrani, Yann De Rycke
PLoS One. 2011; 6(5): e20297. Published online 2011 May 31. doi: 10.1371/journal.pone.0020297
PMCID:
PMC3105053
Abstract Full Text PDF–415K
Distinctive Responsiveness to Stromal Signaling Accompanies Histologic Grade Programming of Cancer Cells
Maria Gloria Luciani, Junhee Seok, Aejaz Sayeed, Stacey Champion, William H. Goodson, Stefanie S. Jeffrey, Wenzhong Xiao, Michael Mindrinos, Ronald W. Davis, Shanaz H. Dairkee
PLoS One. 2011; 6(5): e20016. Published online 2011 May 19. doi: 10.1371/journal.pone.0020016
PMCID:
PMC3098270
Abstract Full Text PDF–1.5M Supplementary Material
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
Markus Ringnér, Erik Fredlund, Jari Häkkinen, Åke Borg, Johan Staaf
PLoS One. 2011; 6(3): e17911. Published online 2011 March 21. doi: 10.1371/journal.pone.0017911
PMCID:
PMC3061871
Abstract Full Text PDF–971K Supplementary Material
Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement
Alan Mackay, Britta Weigelt, Anita Grigoriadis, Bas Kreike, Rachael Natrajan, Roger A’Hern, David S.P. Tan, Mitch Dowsett, Alan Ashworth, Jorge S. Reis-Filho
J Natl Cancer Inst. 2011 April 20; 103(8): 662–673. Published online 2011 March 18. doi: 10.1093/jnci/djr071
PMCID:
PMC3079850
Abstract Full Text PDF–612K Supplementary Material
A Signature Inferred from Drosophila Mitotic Genes Predicts Survival of Breast Cancer Patients
Christian Damasco, Antonio Lembo, Maria Patrizia Somma, Maurizio Gatti, Ferdinando Di Cunto, Paolo Provero
PLoS One. 2011; 6(2): e14737. Published online 2011 February 28. doi: 10.1371/journal.pone.0014737
PMCID:
PMC3046113
Abstract Full Text PDF–931K Supplementary Material
Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures
Cheng Fan, Aleix Prat, Joel S Parker, Yufeng Liu, Lisa A Carey, Melissa A Troester, Charles M Perou
BMC Med Genomics. 2011; 4: 3. Published online 2011 January 9. doi: 10.1186/1755-8794-4-3
PMCID:
PMC3025826
Abstract Full Text PDF–1.5M Supplementary Material
Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer
Armelle Corpet, Leanne De Koning, Joern Toedling, Alexia Savignoni, Frédérique Berger, Charlène Lemaître, Roderick J O'Sullivan, Jan Karlseder, Emmanuel Barillot, Bernard Asselain, Xavier Sastre-Garau, Geneviève Almouzni
EMBO J. 2011 February 2; 30(3): 480–493. Published online 2010 December 21. doi: 10.1038/emboj.2010.335
PMCID:
PMC3034011
Abstract Full Text PDF–1.0M Supplementary Material
Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry
Britta Weigelt, Jorge S Reis-Filho
Breast Cancer Res. 2010; 12(Suppl 4): S5. Published online 2010 December 20. doi: 10.1186/bcr2734
PMCID:
PMC3005725
Full Text PDF–142K
Molecular profiling contributes more than routine histology and immonohistochemistry to breast cancer diagnostics
Christine Shiang, Lajos Pusztai
Breast Cancer Res. 2010; 12(Suppl 4): S6. Published online 2010 December 20. doi: 10.1186/bcr2735
PMCID:
PMC3005726
Full Text PDF–126K
Minimising Immunohistochemical False Negative ER Classification Using a Complementary 23 Gene Expression Signature of ER Status
Qiyuan Li, Aron C. Eklund, Nicolai Juul, Benjamin Haibe-Kains, Christopher T. Workman, Andrea L. Richardson, Zoltan Szallasi, Charles Swanton
PLoS One. 2010; 5(12): e15031. Published online 2010 December 1. doi: 10.1371/journal.pone.0015031
PMCID:
PMC2995741
Abstract Full Text PDF–690K Supplementary Material
Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study
Wenjing Zhou, Karin Jirström, Christine Johansson, Rose-Marie Amini, Carl Blomqvist, Olorunsola Agbaje, Fredrik Wärnberg
BMC Cancer. 2010; 10: 653. Published online 2010 November 30. doi: 10.1186/1471-2407-10-653
PMCID:
PMC3001723
Abstract Full Text PDF–257K
Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature
M Knauer, F Cardoso, J Wesseling, P L Bedard, S C Linn, E J T Rutgers, L J van 't Veer
Br J Cancer. 2010 December 7; 103(12): 1788–1793. Published online 2010 November 16. doi: 10.1038/sj.bjc.6605916
PMCID:
PMC3008599
Abstract Full Text PDF–393K
Page of 3 Next Last
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk